Ulf Krueger has dedicated his entire career to aerosol medicine, combining deep expertise in combination products with an innovative entrepreneurial vision as the founder and CEO of PULMOTREE, a Munich-based company that specializes in developing cutting-edge technologies for targeted pulmonary drug delivery.
He has a biomedical engineering background with extensive experience in the development of respiratory drug delivery systems. His career spans roles in research and development, as well as management positions, where he contributed to the successful commercialization of products at companies such as PARI and Vectura.
As an inventor listed on numerous patents and (co-)author of a variety of publications, Ulf has played a key role in advancing inhalation technologies within the industry. A recognized speaker and conference chairman, who actively contributes to the scientific community not only through his lectures but also through networking and mentorship, including his involvement in the TANDEM program at RWTH Aachen University.
In addition to his work at PULMOTREE, Ulf is also involved in the International Society for Aerosols in Medicine (ISAM) where he chairs the Networking Group “New Devices, Emerging Therapies, and e-Health”, fostering an active platform for collaboration among researchers and industry professionals committed to innovation in inhaled medicines.
